EIF4E and cancer: Conversely, overexpression of 4E-BP (for 4E-Binding Protein, a competitive inhibitor to the eIF4E-eIF4G interaction) in a p53−/− mouse cancer model slowed progression of cancer in part through a mechanism involving premature senescence [33].